WinstonWınston
Back
Stock

Mettler-Toledo International

MTD
65
Medical - Diagnostics & Research · Healthcare
Also trades as: 0K10.L GBP 16.60 (-1.39%)
Price
$1670.29
-14.35 (-0.85%)
Market Cap
$33.47B
Winston Score
65
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Oct 24, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Exceptional
28/30
Growth
Good
12/20
Cash Flow
Exceptional
9/10
Stability
Good
5/10
Valuation
Good
6/10
Ownership
Weak
2/15
Dividends
Not counted
n/a

62 of 95 counted points = Winston Score 65. Pillars marked n/a do not apply to this company and are left out of the total.

Track this stock — start free trial

Share count falling — buybacks

−11.9% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 23.5M (2021) → 20.7M (2025)

§Winston Score History

The full picture

Mettler-Toledo makes precision instruments used to weigh and measure things very accurately. Its main products include laboratory balances, industrial scales, and analytical instruments used in labs, factories, and retail settings. The company sells to customers in pharmaceuticals, chemicals, food manufacturing, and scientific research — industries where getting measurements exactly right is critical.

Mettler-Toledo earns revenue by selling hardware instruments and charging for ongoing services like calibration, maintenance, and software. It operates globally, with significant business in Europe, the Americas, and China, and generates roughly $4 billion in annual revenue. Its competitive edge comes from its reputation for precision and reliability, deep customer relationships, and the high cost of switching to a competitor once its instruments are embedded in a customer's workflow. The biggest risk the company faces is its meaningful exposure to China, where slower economic growth and weaker pharmaceutical spending have already pressured results in recent years.

Politician Trades

6 trades / 12mo

2 Congressional buys and 4 sells on MTD in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+4.5% YoY

YoY Growth Rate

Slow revenue growth

Reported EPS Growth

+18.3% YoY

Quarterly reporting periods ended:

30 Jun 2025: $9.78

30 Jun 2026: $11.57

Reported/statutory EPS, not adjusted or underlying earnings. One-off items can affect this figure. Provider rounding can affect the growth rate.

YoY Growth Rate

Reported EPS increased year over year

R&D Spend

$199M/ year

↑ Rising (+5% vs prior year)

5.0% of revenue

Below sector average (18%)

R&D investment increasing — building for the future

Insider Activity

0.7%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$51M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Mettler-Toledo International is growing revenue at 4% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
61.4%
Premium pricing power — 61.4% gross margin
Profit after running costs
Operating Margin
30.6%
Excellent — 30.6% operating margin
Return on the money invested
ROCE
55.3%
Exceptional — 55.3% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+6.9%
Slow sales growth (+6.9% YoY)
Profit growth
EPS YoY
+12.4%
Earnings growing (+12.4% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
108%
Turns 108% of profit into real cash
Spare cash per sale
FCF Margin
20.9%
Converts sales into free cash efficiently (20.9%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
164.70
Heavy debt load (164.70)
Covers its interest
Interest Cover
16.94x
Comfortably covers interest (16.9x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
37.5x
Pricey — P/E 37.5

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+10.9
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (37.5 → 26.6)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial